Garcia-Argibay, M., Chang, Z., Brikell, I., Kuja-Halkola, R., D'Onofrio, B. M., Lichtenstein, P., . . . Cortese, S. (2025). Evaluating ADHD medication trial representativeness. Lancet psychiatry, 12(2), 131. https://doi.org/10.1016/S2215-0366(24)00396-1
Chicago-referens (17:e uppl.)Garcia-Argibay, Miguel, et al. "Evaluating ADHD Medication Trial Representativeness." Lancet Psychiatry 12, no. 2 (2025): 131. https://doi.org/10.1016/S2215-0366(24)00396-1.
MLA-referens (9:e uppl.)Garcia-Argibay, Miguel, et al. "Evaluating ADHD Medication Trial Representativeness." Lancet Psychiatry, vol. 12, no. 2, 2025, p. 131, https://doi.org/10.1016/S2215-0366(24)00396-1.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.
